[go: up one dir, main page]

WO2001021138A1 - Antimicrobial topical composition and methods - Google Patents

Antimicrobial topical composition and methods Download PDF

Info

Publication number
WO2001021138A1
WO2001021138A1 PCT/US2000/025853 US0025853W WO0121138A1 WO 2001021138 A1 WO2001021138 A1 WO 2001021138A1 US 0025853 W US0025853 W US 0025853W WO 0121138 A1 WO0121138 A1 WO 0121138A1
Authority
WO
WIPO (PCT)
Prior art keywords
topical composition
antimicrobial
water
component
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/025853
Other languages
French (fr)
Inventor
Edward B. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Scientific Inc
Original Assignee
First Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Scientific Inc filed Critical First Scientific Inc
Priority to AU75980/00A priority Critical patent/AU7598000A/en
Publication of WO2001021138A1 publication Critical patent/WO2001021138A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/12Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Definitions

  • the present invention relates to an antimicrobial topical composition including a quaternary ammonium compound as the active antimicrobial component thereof.
  • the present invention relates to topical compositions with an antimicrobial component including benzethonium chloride, a cationic surfactant component for cleansing the skin and for emulsifying the hydrophobic components of the topical composition, and substantially no low molecular weight alcohols.
  • the present invention also relates to products including the antimicrobial topical composition and to methods of making and using the antimicrobial topical composition.
  • Antimicrobial topical compositions are commonly used by healthcare personnel, in biological laboratories, and in other settings where the elimination of bacteria from the skin is desired. In the healthcare and laboratory settings, personnel are encouraged to wash their hands frequently, often several times each day, in order to prevent the transfer of microorganisms and to reduce the likelihood of infection or contamination by microorganisms.
  • antimicrobial topical compositions have taken the form of soaps.
  • Other types of antimicrobial topical compositions such as lotions, gels, and foams, have also been used.
  • these antimicrobial topical compositions are formulated with sufficient concentrations of antimicrobial agents to kill bacteria on contact or during exposure times of a few seconds.
  • antimicrobial topical compositions include large amounts of low molecular weight alcohols (i.e., alcohols having up to four carbon atoms), such as ethanol or isopropyl alcohol.
  • the low molecular weight alcohol in these compositions is effective in killing bacteria, but tends to dry the skin.
  • antimicrobial topical compositions include iodine, triclosan, parachlorometaxylenol (“PCMX”), chlorhexidine gluconate (“CHG”), or hexachloropitine as the active antimicrobial components thereof.
  • PCMX parachlorometaxylenol
  • CHG chlorhexidine gluconate
  • antimicrobial topical compositions containing each of these antimicrobial components may also cause dry skin or otherwise irritate the skin.
  • Some antimicrobial topical compositions include other antimicrobial components.
  • quaternary ammonium compounds are used in the antimicrobial topical compositions disclosed in United States Patent 5,244,666 (hereinafter “the '666 Patent”), issued to Jack C. Murley on September 14, 1993; United States Patents 5,492,932 (hereinafter “the '932 Patent”) and 5,767,163 (hereinafter “the '163 Patent”), issued to Ruth B. Kundsin on February 20, 1996, and June 16, 1998, respectively; and European patent 0 389 648 Bl .
  • Quaternary ammonium compounds are used as an antimicrobial component of some of these compositions, and as a cationic surfactant in others.
  • quaternary ammonium compounds are surfactants, if used in a topical composition in high concentrations, quaternary ammonium compounds may remove oils and, thus, moisture, from skin upon rinsing the topical composition from the skin. High concentrations of quaternary ammonium compounds may also irritate the skin.
  • the '666 Patent discloses a composition that may be used as pre-operative skin scrub or as a topical disinfectant.
  • the composition of the '666 Patent has two antimicrobial components, a quaternary ammonium compound and a substituted phenolic compound.
  • the quaternary ammonium compound is described as a phosphate imidazolinium or phosphate quaternary compound.
  • the composition contains approximately 3% by weight of each of the quaternary ammonium compound and the substituted phenolic compound.
  • a quaternary ammonium compound as a surgical scrub is somewhat undesirable in that, upon scrubbing the skin, the quaternary ammonium compound can emulsify oils in the skin, which are subsequently removed from the skin when the surgical scrub is rinsed from the skin.
  • the composition disclosed in the '666 Patent may cause dry skin or may otherwise irritate the skin.
  • the '932 and ' 163 Patents each disclose a lubricating, germicidal topical composition that includes isopropyl alcohol, cetyl alcohol, glycolic acid, and a quaternary ammonium salt such as benzalkonium chloride.
  • Benzalkonium chloride makes up about 0.017% to about 0.26% of the weight of the composition, while isopropyl alcohol constitutes about 90-98% of the weight of the composition.
  • the '932 and ' 163 Patents each state that the isopropyl alcohol and benzalkonium chloride of the composition impart antimicrobial properties to the composition.
  • the combination of benzalkonium chloride and isopropyl alcohol is disclosed to provide substantially instantaneous disinfection on contact and also provides a synergistic effect which increases each ingredient's germicidal activity.
  • the composition also contains cetyl alcohol and a lubricating amount of glycolic acid to prevent drying of the skin by the isopropyl alcohol. When applied to the skin, the dried composition provides a persistent residual film until washed off with conventional soap and water.
  • the composition is disclosed to be beneficial in combination with a hand wash containing a detergent or antiseptic. Therefore, the composition of the '932 and ' 163 Patents cannot be used alone as a soap.
  • the germicidal residue can last up to one year on a hard surface if left undisturbed.
  • compositions are relatively watery solutions.
  • European patent application 0 389 648 Bl discloses a composition that is useful for decontaminating or disinfecting purposes and that may be metered by a soap dispenser.
  • the composition includes benzalkonium chloride as a cationic surfactant.
  • Benzalkonium chloride constitutes at least about 5% of the composition, by weight.
  • the composition has antimicrobial properties. As stated previously, however, the use of such a high concentration of cationic surfactants can dry or irritate the skin, making the composition disclosed in European patent application 0 389 648 Bl somewhat undesirable.
  • Lotions and creams that include quaternary ammonium compounds are also known.
  • lotions and creams are either water-in-oil or oil-in-water emulsions that have at least about 25% oils, or hydrophobic materials.
  • Conventional creams and lotions have such high oil contents to facilitate stability of the emulsions and to impart the creams and lotions with cream, smooth textures.
  • Examples of creamy, stable emulsion topical compositions that include quaternary ammonium compounds are disclosed in United States Patents 5,759,557 (hereinafter “the '557 Patent”) and 5,759,558 (hereinafter “the '558 Patent”), both issued to Howard Epstein et al.
  • R 4 > where R, and R 2 are each long chain, substantially linear alkyl groups having from about 16 to about 22 carbon atoms, R 3 and R 4 are each alkyl groups having from about 1 to about 3 carbon atoms, and X is a salt-forming anion (i.e., negatively charged ion) when the quaternary ammonium compound is dissolved in water. Quaternary ammonium compounds make up about 3% to about 8% of the weight of the moisturizing cream or lotion.
  • the '557 and '558 Patents each provide that these quaternary ammonium compounds are useful as moisturizers due to their hard, waxy, and non-sticky characteristics.
  • the composition described in the '557 and '558 Patents is not disclosed to be useful as a soap.
  • the '061 Patent discloses a protective hand lotion consisting of aloe vera gel, vitamin E gel, petroleum jelly, and an emulsion component composed of water and various hydrophilic and hydrophobic ingredients.
  • the emulsion component which makes up about 70 to about 88 percent of the weight of the lotion, includes a quaternary ammonium salt, dimethyl distearyl ammonium chloride, as the emulsifier.
  • the quaternary ammonium salt makes up about 4% of the weight of the emulsion component.
  • the lotion of the '061 Patent does not rinse off of the skin, but rather acts as a protective barrier to provide protection against normal handwashing procedures with soap and water for up to three handwashings.
  • compositions disclosed in the '557, '558, and '061 Patents are creams or lotions that are not intended to be rinsed from the skin. None of these patents discloses that the quaternary ammonium compounds thereof are useful as antimicrobials.
  • the topical compositions disclosed in each of the '557, '558, and '061 Patents has a relatively high content of hydrophobic components.
  • the hydrophobic components of the topical compositions disclosed in the '061 Patent make up at least about 25% of the weight of the topical compositions.
  • the embodiment disclosed in EXAMPLE 1 includes JOHNSON'S baby lotion, which is known in the art to include at least about 25% mineral oil and other hydrophobic components. Of the remaining ingredients of the composition, petroleum jelly alone makes up about 28% of the weight thereof.
  • the embodiment of the topical composition disclosed in EXAMPLE 2 has about 28% petroleum jelly, by weight.
  • the antimicrobial properties of the quaternary ammonium compounds in these topical compositions may be diminished or completely masked.
  • the art does not teach an antimicrobial topical composition that has a quaternary ammonium compound as the antimicrobial component thereof in an amount that will not irritate or dry the skin and moisturizers that will not significantly diminish the antimicrobial activity of the antimicrobial component.
  • the present invention includes a topical composition, such as a lotion or a spray.
  • a topical composition incorporating teachings of the present invention is substantially free of low molecular weight alcohols (i.e., alcohols, such as methanol, ethanol, propyl alcohols, and butyl alcohols, that include from 1 to 4 carbon atoms) and includes a quaternary ammonium compound as an antimicrobial agent.
  • the topical composition also includes a hydrophobic (i.e., "fat hating") component and a cationic surfactant component for cleansing skin and emulsifying the hydrophobic component in water.
  • a topical composition according to the present invention may also include other components, such as moisturizing agents, therapeutic agents, medicinal agents, fragrances, botanical extracts, preservatives, and pH adjusting agents.
  • low molecular weight alcohols which are commonly employed as antimicrobial ingredients of topical compositions, can remove moisture-providing oils from the skin. Low molecular weight alcohols may also cause pain in open skin wounds. Accordingly, the topical composition of the present invention is substantially free of low molecular weight alcohols.
  • the antimicrobial component of the topical composition of the present invention preferably includes a quaternary ammonium compound that kills microorganisms by disrupting, or forming holes in, the biological membranes of many microorganisms. When the membranes of many microorganisms are disrupted, the various parts of the microorganism leak out or harmful materials enter the membrane, effectively killing the microorganism.
  • the quaternary ammonium compound known in the art as benzethonium chloride is preferred for use in the topical composition of present invention.
  • the antimicrobial component of the topical composition includes a quaternary ammonium compound that, when diluted to a 1% solution, will kill microorganisms such as E. coli, Staphylococcus species, and Pseudomonas species or at least hold these microorganisms at stasis, or prevent significant growth of the number of microorganisms.
  • the quaternary ammonium compound of the antimicrobial component of the topical composition also preferably "kills" viruses, such as the herpes simplex viruses (type-1 and type-2) (HSV-1 and HSV-2) and rhinovirus.
  • the quaternary ammonium compound of the antimicrobial component may make up about 1% of the weight of the topical composition.
  • the quaternary ammonium compound makes up about 0.1 to about 0.2% of the total weight of the topical composition.
  • hydrophobic materials examples include, without limitation, fragrances and botanical oils.
  • Hydrophobic materials that moisturize, protect, act as emollients, or otherwise therapeutically benefit the skin are another example of hydrophobic materials that can be employed as the hydrophobic component of the topical composition according to the present invention.
  • Water soluble moisturizers and emollients may also be employed.
  • moisturizers or emollients When moisturizers or emollients are employed in the topical composition of the present invention, the moisturizers or emollients employed or the proportions in which the moisturizers or emollients are employed preferably do not significantly diminish the antimicrobial activity of the quaternary ammonium compound of the antimicrobial component of the topical composition.
  • exemplary moisturizers and emollients that can be included in the topical composition include, without limitation, glycerol, petrolatum, mineral oil, and silicone oils.
  • Hydrophobic (i.e.. "water hating") components of the topical composition can be emulsified, or suspended, in the water of the topical composition with surfactants.
  • surfactants which are also commonly referred to in the art as emulsifiers. Since quaternary ammonium compounds are cationic, or positively charged ionic, compounds, anionic substances, such as anionic surfactants, may diminish the antimicrobial and other properties of the quaternary ammonium compound.
  • the surfactants that are used in the topical composition to emulsify the hydrophobic components thereof are preferably cationic surfactants.
  • a cationic surfactant has a hydrophilic (i.e., "water loving") head and a lipophilic (i.e., "fat loving") tail.
  • a hydrophobic material such as a silicone oil
  • the lipophilic tails of a number of surfactant molecules implant themselves into a quantity of the hydrophobic material to form a surfactant-coated droplet of the hydrophobic material, or micelle.
  • the positively charged portion of a cationic surfactant is the hydrophilic portion thereof, which faces away from the hydrophobic material and toward the water, or aqueous, portion of the emulsion.
  • micelles are removed from an aqueous environment, such as the water of the topical composition, by evaporating the water or otherwise, the micelles release the droplet hydrophobic material.
  • one or more quaternary ammonium compounds are employed as a cationic surfactant component of the topical composition of the present invention.
  • the surfactant or surfactants of the cationic surfactant component are preferably used in the topical composition of the present invention in concentrations that are not irritating to tissues of the body, such as skin.
  • the topical composition may also include a preservative component of one or more preservatives.
  • the topical composition includes a blend of two or more preservatives.
  • a method for manufacturing the topical composition includes mixing water soluble components of the topical composition in the water to form an aqueous solution, and separately mixing emulsifiers into the hydrophobic component of the topical composition.
  • the mixture of the hydrophobic component and surfactant is heated.
  • the aqueous solution is gradually added to the mixture of the hydrophobic component and surfactant while agitating the mixture to form a water-in-oil emulsion.
  • the concentration of the aqueous solution in the mixture increases, the emulsion inverts from a water-in-oil emulsion to an oil-in-water emulsion.
  • the topical composition is disposed on a sheet to form a wet wipe product.
  • Woven or non- woven sheets of the types known to be useful for forming wet wipes are useful in the wet wipe product of the present invention.
  • the sheet is impregnated or wetted with the topical composition of the present invention to form the wet wipe product.
  • the topical composition is applied in a thin layer to skin, the water evaporated from the topical composition, and the antimicrobial component or components released onto the skin.
  • the topical composition can be applied to skin directly, such as in a spray, or by way of a wet wipe including the topical composition.
  • the topical composition can be rinsed from the skin soon after application thereof, in which case the topical composition is used similar to the manner in which soaps are used.
  • the present invention includes an antimicrobial topical composition with an antimicrobial component including a quaternary ammonium compound in a stable emulsion of water and oil.
  • the oil is suspended in the water with at least one cationic surfactant.
  • the antimicrobial topical composition of the present invention is substantially free of low molecular weight alcohols.
  • the antimicrobial component of the topical composition includes a sufficient amount of the quaternary ammonium compound that, when diluted to a 1% solution, the quaternary ammonium compound will kill microorganisms such as E. coli, Staphylococcus species, and Pseudomonas species, as well as viruses such as herpes simplex viruses and rhinoviruses, or at least hold these microorganisms at stasis, thereby preventing a significant increase in the number of microorganisms exposed to the 1% solution and, thus, decreasing the likelihood of infection by microorganisms as a result of their presence on skin.
  • microorganisms such as E. coli, Staphylococcus species, and Pseudomonas species
  • viruses such as herpes simplex viruses and rhinoviruses
  • the quaternary ammonium compound employed as the antimicrobial component of the topical composition of the present invention can constitute up to about 1% of the weight of the topical composition.
  • the quaternary ammonium compound of the antimicrobial component makes up from about 0.1% to about 0.2% of the weight of the topical composition.
  • the antimicrobial component of the topical composition preferably includes the quaternary ammonium compound known in the art as benzethonium chloride, which has the chemical formula:
  • the hydrophobic component of the topical composition of the present invention can include hydrophobic, or oil-based, materials, such as oil-based fragrances, oil-based botanical extracts, and hydrophobic materials that moisturize, protect, or otherwise therapeutically benefit the skin.
  • the topical composition In order to emulsify, or suspend, the hydrophobic (i.e., "water hating") components of the topical composition in the water, or aqueous, portion of the topical composition, the topical composition also includes one or more surfactants.
  • the surfactants used in the topical composition are present in amounts that will not irritate external tissues of the body, such as skin, with prolonged or frequent use.
  • the surfactants used in the topical composition are preferably cationic surfactants. This is because cationic surfactants are more compatible than other types of surfactants with the quaternary ammonium compound of the antimicrobial component of the topical composition and are, therefore, less likely than other types of surfactants to interfere with the antimicrobial activity or other properties of the quaternary ammonium compounds.
  • Exemplary cationic surfactants that may be used in the topical composition are quaternary ammonium compounds.
  • One such class of quaternary ammonium compounds is benzalkonium chloride, which has the general formula:
  • quaternary ammonium compounds that may be used in the cationic surfactant component of the topical composition of the present invention include, without limitation, didecyldimethyl ammonium chloride (DDAC), dioctyldimethyl ammonium chloride (DOAC), and octyldecyldimethyl ammonium chloride (DODAC).
  • DDAC didecyldimethyl ammonium chloride
  • DOAC dioctyldimethyl ammonium chloride
  • DODAC octyldecyldimethyl ammonium chloride
  • quaternary ammonium compounds that are useful in the cationic surfactant component of the topical composition have the chemical formula:
  • R, and R 2 both include alkyl groups
  • R, and R 2 both include benzyl groups, or one of R, and R 2 includes a benzyl group and the other of R, and R 2 includes an alkyl group.
  • the quaternary ammonium compounds preferably comprise up to about 1% to about 2% of the weight of the topical composition. More preferably, quaternary ammonium compounds that are employed in the topical composition as cationic surfactants collectively constitute about 0.1 % to about 0.5% or about 0.1% to about 1% of the weight of the topical composition.
  • Behentrimonium methosulfate is an example of another surfactant that can be used in the topical composition of the present invention.
  • the topical composition may also include a preservative component with one or more preservatives.
  • the topical composition includes a blend of two or more preservatives.
  • preservatives prevent the growth of microorganisms, such as bacteria, molds, and fungi.
  • a blend of preservatives can facilitate a broader spectrum of activity if the preservatives of the blend prevent the growth of different microorganisms.
  • Combinations of preservatives may also be capable of preventing the growth of microorganisms against which the individual preservatives may not be effective.
  • the total amount of one or more preservatives in the blend can be reduced without reducing the level of activity of those preservatives.
  • the targeted microorganisms are less likely to develop resistance to any one of the preservatives in the blend.
  • certain blends of preservatives are synergistic.
  • the preferred combination of preservatives includes a one or more parabens.
  • the parabens prevent or control the growth of bacterial microorganisms.
  • Exemplary parabens that can be used in the topical composition include, but are not limited to, methylparabens, ethylparabens, propylparabens, and butylparabens.
  • the topical composition of the present invention includes methylparaben and propylparaben.
  • Another exemplary preservative that may be employed in the topical composition of the present invention is a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4- isothiazolin-3-one.
  • Potassium sorbate and other sorbic acid preservatives are examples of other preservatives that can be used in the topical composition.
  • Topical compositions that include other preservatives and other mixtures of preservatives are also within the scope of the present invention.
  • the topical composition may also include other components, such as fragrances. botanical extracts, pH adjusting agents, or antimicrobial agents. Fragrances may be added to enhance the appeal of the product to consumers.
  • the fragrances can be water soluble or oil-based.
  • Botanical extracts, including both water soluble and hydrophobic materials, may be added to enhance the appeal of the product to consumers, impart a softer feel to the product, or help build healthier skin.
  • the pH of the formulation can be controlled to avoid irritation to the user's skin, extend shelf-life, and generally enhance the product. Without pH adjusting agents, the pH of the topical composition may change over time, especially if there are long periods of time between manufacture and use of the product.
  • the topical composition of the present invention preferably includes a pH adjusting agent.
  • the pH adjusting agent used in the topical composition does not irritate or have any other substantial adverse effects on skin.
  • Exemplary pH adjusting agents that can be used in the topical composition include, but are not limited to, acids, such as sorbic acid, citric acid, or benzoic acid, bases, and known buffers.
  • acids such as sorbic acid, citric acid, or benzoic acid
  • bases such as sorbic acid, citric acid, or benzoic acid
  • known buffers such as glycerol, glycerol, glycerol, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium
  • topical composition can serve dual roles.
  • potassium sorbate could be used in the topical composition as both a pH adjusting agent and as a preservative.
  • One embodiment of the topical composition of the present invention is a stable, creamy emulsion that includes moisturizers and emollients. Hydrophilic moisturizers or emollients, such as glycerol, or hydrophobic moisturizers or emollients, such as silicone oils, mineral oils, and petrolatum, can be used in the topical composition.
  • EXAMPLE illustrates, by way of example and not by way of limitation, a specific formulation of the stable, creamy emulsion embodiment of the topical composition of the present invention:
  • the stable, creamy emulsion embodiment of the topical composition of the present invention preferably includes hydrophobic materials and other components in proportions that will not significantly diminish the antimicrobial properties of the antimicrobial quaternary ammonium compound (e.g., benzethonium chloride) of the topical composition.
  • hydrophobic materials make up less than about 20%) of the weight of the topical composition. More preferably, the topical composition has less than about 17% hydrophobic materials, by weight. Topical compositions that include less than about 15% hydrophobic materials, by weight, are even more preferred.
  • Stable, creamy emulsions with these proportions of hydrophobic materials can be manufactured in accordance with the hereinafter described method, in which the water soluble components of the topical composition, such as the quaternary ammonium compound of the antimicrobial component, are mixed in the water to form an aqueous solution, and the cationic surfactants, or emulsifiers, are separately mixed into the hydrophobic component of the topical composition.
  • the water soluble components of the topical composition such as the quaternary ammonium compound of the antimicrobial component
  • the mixture of the hydrophobic component and surfactant is heated to facilitate the formation of an emulsion of the desired consistency.
  • the hydrophobic component and surfactant mixture is heated to a temperature of about 60° C. to about 100° C. Temperatures in the range of about 70° C. to about 90° C. are more preferred.
  • the aqueous solution may be heated to a temperature of about 75 ° C. to about 80° C. while being mixed, while the hydrophobic component and surfactant mixture may be heated to a temperature of about 85 ° C. to about 90° C. while being mixed.
  • Components of the topical composition that are sensitive to heat may be left out of the aqueous solution, the hydrophobic component, or the mixture until after the emulsion is cooled to a temperature that will not affect the activities of these heat-sensitive components. While the hydrophobic component and surfactant mixture is maintained at a substantially constant temperature, the aqueous solution is gradually added to the mixture with sufficient agitation to form small droplets of the aqueous solution in the hydrophobic component and, thus, to form a water-in-oil emulsion. The water-in-oil emulsion is preferably maintained at an increased temperature while the aqueous solution is mixed therein.
  • the emulsion inverts from a water-in-oil emulsion to an oil-in-water emulsion.
  • the remainder of the aqueous solution can be added to the emulsion at an increased rate until the desired proportions of aqueous solution and hydrophobic components have been obtained.
  • Mixing of the emulsion may be continued as the temperature thereof is decreased to a gel point of the emulsion and to cooler temperatures.
  • the topical composition of the present invention is a more dilute, liquid emulsion that includes a small proportion of hydrophobic components.
  • This liquid embodiment of the topical composition may have about 95% or more water, by weight.
  • EXAMPLE illustrates, by way of example and not by way of limitation, a specific formulation of a liquid, or less viscous, embodiment of the topical composition of the present invention:
  • the less viscous embodiments of the topical composition can be manufactured by known processes or by employing the method described above in reference to the manufacture of the stable, creamy emulsion embodiment of the topical composition, then further diluting the composition to the desired consistency.
  • topical compositions incorporating teachings of the present invention, including the stable, creamy emulsion embodiments, as well as the less viscous embodiments
  • the topical composition may be rubbed onto to skin (e.g., on hands).
  • skin e.g., on hands
  • the topical composition of the present invention eliminates many microorganisms, including bacteria and some viruses.
  • the topical composition can be left on the skin, wherein water evaporates from the skin and the remaining components of the topical composition, such as antimicrobial component, the hydrophobic components, and the surfactants remain on the skin or are absorbed into the skin.
  • the topical composition demonstrates prolonged activity against some microorganisms.
  • the topical composition remains active against Staphylococcus aureus for as long as four hours or more.
  • the number of S. aureus on the skin was about 98.8% less than the number of S. aureus on the skin prior to application of the topical composition.
  • the topical composition remains effective against E. coli for at least about two hours. After fifteen seconds, the topical composition reduces the number of E. coli by about 99.999%. At ten minutes following application of the topical composition, the number of E. coli increased, but remained at about 55.3% less than the number of E. coli prior to application of the topical composition. After two hours, the number of E. coli on the skin was still about 36.9% less than the number of E. coli prior to application of the topical composition.
  • the topical composition can be removed from the skin, such as by rinsing with water (i.e., used similarly to a soap).
  • water i.e., used similarly to a soap.
  • a topical composition with less than about 20%, by weight, hydrophobic components does not leave a tacky or oily residue on the skin, as may occur with many conventional creamy emulsions that have higher proportions of hydrophobic components.
  • Topical compositions incorporating teachings of the present invention are also effective in reducing populations of Mycobacterium Bovis, which causes tuberculosis.
  • Mycobacterium Bovis When Mycobacterium Bovis is exposed to an exemplary topical composition incorporating teachings of the present invention, the population of Mycobacterium Bovis is reduced by about 96.3%.
  • the exposure time is increased to about 30 seconds, the number of Mycobacterium Bovis bacteria is reduced by about 91.4%.
  • Topical compositions incorporating teachings of the present invention may also have antiviral activities. These antiviral activities may be exhibited with long exposure times, as well as with relatively short exposure times, such as when the topical composition is applied to the skin and, shortly thereafter, removed from the skin.
  • Topical compositions according to the present invention may also kill viruses when left on the skin for longer periods of time.
  • the following TABLE includes examples of viruses against which the topical composition of EXAMPLE 2, as well as other embodiments of topical compositions incorporating teachings of the present invention, is effective.
  • the topical compositions of the present invention may reduce the number of viruses significantly, such as by greater than about 99%, in exposure times as short as about 15 seconds or less.
  • the liquid embodiment of the topical composition is disposed on a sheet to form a wet wipe product.
  • Woven or non- woven sheets of the types known to be useful for forming wet wipes are useful in the wet wipe product of the present invention.
  • the sheet is impregnated or wetted with the topical composition of the present invention to form the wet wipe product.
  • the liquid embodiment of the topical composition is applied in a thin layer to skin, the water evaporated from the topical composition, and the antimicrobial component released onto the skin.
  • the topical composition can be applied to skin directly, by spraying, or by way of a wet wipe including the liquid topical composition.
  • the liquid embodiment of the topical composition reduces the number of bacteria and virus particles on the skin in a manner similar to that of the creamy emulsion embodiment of the topical composition.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

An antimicrobial topical composition including a quatenary ammonium compound in the antimicrobial component thereof. The quatenary ammonium compound may be benzethonium chloride. Benzethonium may constitute up to about 1% of the weight of the topical composition. The topical composition also has water and a cationic surfactant component for cleansing and to emulsify any hydrophobic components in the water. The topical composition my be a lotion that includes a stable, creamy emulsion of the hydrophobic component in the water or a more dilute liquid emulsion. The invention also includes wipe sheets wetted or impregnated with the topical composition. The topical composition can be applied to the skin and left thereon or removed from the skin by rinsing. The invention also includes methods for manufacturing the topical composition.

Description

ANTIMICROBIAL TOPICAL COMPOSITION AND METHODS
TECHNICAL FIELD The present invention relates to an antimicrobial topical composition including a quaternary ammonium compound as the active antimicrobial component thereof. Particularly, the present invention relates to topical compositions with an antimicrobial component including benzethonium chloride, a cationic surfactant component for cleansing the skin and for emulsifying the hydrophobic components of the topical composition, and substantially no low molecular weight alcohols. The present invention also relates to products including the antimicrobial topical composition and to methods of making and using the antimicrobial topical composition.
BACKGROUND ART Antimicrobial topical compositions are commonly used by healthcare personnel, in biological laboratories, and in other settings where the elimination of bacteria from the skin is desired. In the healthcare and laboratory settings, personnel are encouraged to wash their hands frequently, often several times each day, in order to prevent the transfer of microorganisms and to reduce the likelihood of infection or contamination by microorganisms.
Conventionally, antimicrobial topical compositions have taken the form of soaps. Other types of antimicrobial topical compositions, such as lotions, gels, and foams, have also been used. In order to effectively reduce the number of bacteria and other microorganisms on skin to acceptable levels, these antimicrobial topical compositions are formulated with sufficient concentrations of antimicrobial agents to kill bacteria on contact or during exposure times of a few seconds.
For example, many of antimicrobial topical compositions include large amounts of low molecular weight alcohols (i.e., alcohols having up to four carbon atoms), such as ethanol or isopropyl alcohol. The low molecular weight alcohol in these compositions is effective in killing bacteria, but tends to dry the skin.
Other conventional antimicrobial topical compositions include iodine, triclosan, parachlorometaxylenol ("PCMX"), chlorhexidine gluconate ("CHG"), or hexachloropitine as the active antimicrobial components thereof. Like alcohol, with frequent use, antimicrobial topical compositions containing each of these antimicrobial components may also cause dry skin or otherwise irritate the skin.
Some antimicrobial topical compositions include other antimicrobial components. For example, quaternary ammonium compounds are used in the antimicrobial topical compositions disclosed in United States Patent 5,244,666 (hereinafter "the '666 Patent"), issued to Jack C. Murley on September 14, 1993; United States Patents 5,492,932 (hereinafter "the '932 Patent") and 5,767,163 (hereinafter "the '163 Patent"), issued to Ruth B. Kundsin on February 20, 1996, and June 16, 1998, respectively; and European patent 0 389 648 Bl . Quaternary ammonium compounds are used as an antimicrobial component of some of these compositions, and as a cationic surfactant in others. Since quaternary ammonium compounds are surfactants, if used in a topical composition in high concentrations, quaternary ammonium compounds may remove oils and, thus, moisture, from skin upon rinsing the topical composition from the skin. High concentrations of quaternary ammonium compounds may also irritate the skin.
The '666 Patent discloses a composition that may be used as pre-operative skin scrub or as a topical disinfectant. The composition of the '666 Patent has two antimicrobial components, a quaternary ammonium compound and a substituted phenolic compound. The quaternary ammonium compound is described as a phosphate imidazolinium or phosphate quaternary compound. The composition contains approximately 3% by weight of each of the quaternary ammonium compound and the substituted phenolic compound. The use of such a high concentration of a quaternary ammonium compound as a surgical scrub is somewhat undesirable in that, upon scrubbing the skin, the quaternary ammonium compound can emulsify oils in the skin, which are subsequently removed from the skin when the surgical scrub is rinsed from the skin. Thus, the composition disclosed in the '666 Patent may cause dry skin or may otherwise irritate the skin.
The '932 and ' 163 Patents each disclose a lubricating, germicidal topical composition that includes isopropyl alcohol, cetyl alcohol, glycolic acid, and a quaternary ammonium salt such as benzalkonium chloride. Benzalkonium chloride makes up about 0.017% to about 0.26% of the weight of the composition, while isopropyl alcohol constitutes about 90-98% of the weight of the composition. The '932 and ' 163 Patents each state that the isopropyl alcohol and benzalkonium chloride of the composition impart antimicrobial properties to the composition. The combination of benzalkonium chloride and isopropyl alcohol is disclosed to provide substantially instantaneous disinfection on contact and also provides a synergistic effect which increases each ingredient's germicidal activity. The composition also contains cetyl alcohol and a lubricating amount of glycolic acid to prevent drying of the skin by the isopropyl alcohol. When applied to the skin, the dried composition provides a persistent residual film until washed off with conventional soap and water. The composition is disclosed to be beneficial in combination with a hand wash containing a detergent or antiseptic. Therefore, the composition of the '932 and ' 163 Patents cannot be used alone as a soap. In addition, the germicidal residue can last up to one year on a hard surface if left undisturbed.
Each of these compositions are relatively watery solutions.
European patent application 0 389 648 Bl discloses a composition that is useful for decontaminating or disinfecting purposes and that may be metered by a soap dispenser. The composition includes benzalkonium chloride as a cationic surfactant. Benzalkonium chloride constitutes at least about 5% of the composition, by weight. The composition has antimicrobial properties. As stated previously, however, the use of such a high concentration of cationic surfactants can dry or irritate the skin, making the composition disclosed in European patent application 0 389 648 Bl somewhat undesirable.
Lotions and creams that include quaternary ammonium compounds are also known. Typically, lotions and creams are either water-in-oil or oil-in-water emulsions that have at least about 25% oils, or hydrophobic materials. Conventional creams and lotions have such high oil contents to facilitate stability of the emulsions and to impart the creams and lotions with cream, smooth textures. Examples of creamy, stable emulsion topical compositions that include quaternary ammonium compounds are disclosed in United States Patents 5,759,557 (hereinafter "the '557 Patent") and 5,759,558 (hereinafter "the '558 Patent"), both issued to Howard Epstein et al. on June 2, 1998; and United States Patent 5,869,061 (hereinafter "the '061 Patent"), issued to Bertie Sue Brugh on February 9, 1999. The '557 and '558 Patents disclose moisturizing creams or lotions that are oil-in-water emulsions and that contain a quaternary ammonium compound of the general formula:
R2 I
[R, - N - R3]+ X-
R4 > where R, and R2 are each long chain, substantially linear alkyl groups having from about 16 to about 22 carbon atoms, R3 and R4 are each alkyl groups having from about 1 to about 3 carbon atoms, and X is a salt-forming anion (i.e., negatively charged ion) when the quaternary ammonium compound is dissolved in water. Quaternary ammonium compounds make up about 3% to about 8% of the weight of the moisturizing cream or lotion. The '557 and '558 Patents each provide that these quaternary ammonium compounds are useful as moisturizers due to their hard, waxy, and non-sticky characteristics. The composition described in the '557 and '558 Patents is not disclosed to be useful as a soap.
The '061 Patent discloses a protective hand lotion consisting of aloe vera gel, vitamin E gel, petroleum jelly, and an emulsion component composed of water and various hydrophilic and hydrophobic ingredients. The emulsion component, which makes up about 70 to about 88 percent of the weight of the lotion, includes a quaternary ammonium salt, dimethyl distearyl ammonium chloride, as the emulsifier. The quaternary ammonium salt makes up about 4% of the weight of the emulsion component. The lotion of the '061 Patent does not rinse off of the skin, but rather acts as a protective barrier to provide protection against normal handwashing procedures with soap and water for up to three handwashings.
The topical compositions disclosed in the '557, '558, and '061 Patents are creams or lotions that are not intended to be rinsed from the skin. None of these patents discloses that the quaternary ammonium compounds thereof are useful as antimicrobials.
Moreover, the topical compositions disclosed in each of the '557, '558, and '061 Patents has a relatively high content of hydrophobic components. The hydrophobic components of the topical compositions disclosed in the '061 Patent make up at least about 25% of the weight of the topical compositions. The embodiment disclosed in EXAMPLE 1 includes JOHNSON'S baby lotion, which is known in the art to include at least about 25% mineral oil and other hydrophobic components. Of the remaining ingredients of the composition, petroleum jelly alone makes up about 28% of the weight thereof. Similarly, the embodiment of the topical composition disclosed in EXAMPLE 2 has about 28% petroleum jelly, by weight. As a result of the high content of hydrophobic components in these topical compositions, the antimicrobial properties of the quaternary ammonium compounds in these topical compositions may be diminished or completely masked. Thus, the art does not teach an antimicrobial topical composition that has a quaternary ammonium compound as the antimicrobial component thereof in an amount that will not irritate or dry the skin and moisturizers that will not significantly diminish the antimicrobial activity of the antimicrobial component.
DISCLOSURE OF INVENTION
The present invention includes a topical composition, such as a lotion or a spray. A topical composition incorporating teachings of the present invention is substantially free of low molecular weight alcohols (i.e., alcohols, such as methanol, ethanol, propyl alcohols, and butyl alcohols, that include from 1 to 4 carbon atoms) and includes a quaternary ammonium compound as an antimicrobial agent. The topical composition also includes a hydrophobic (i.e., "fat hating") component and a cationic surfactant component for cleansing skin and emulsifying the hydrophobic component in water. A topical composition according to the present invention may also include other components, such as moisturizing agents, therapeutic agents, medicinal agents, fragrances, botanical extracts, preservatives, and pH adjusting agents.
As stated above, low molecular weight alcohols, which are commonly employed as antimicrobial ingredients of topical compositions, can remove moisture-providing oils from the skin. Low molecular weight alcohols may also cause pain in open skin wounds. Accordingly, the topical composition of the present invention is substantially free of low molecular weight alcohols.
The antimicrobial component of the topical composition of the present invention preferably includes a quaternary ammonium compound that kills microorganisms by disrupting, or forming holes in, the biological membranes of many microorganisms. When the membranes of many microorganisms are disrupted, the various parts of the microorganism leak out or harmful materials enter the membrane, effectively killing the microorganism. The quaternary ammonium compound known in the art as benzethonium chloride is preferred for use in the topical composition of present invention.
Preferably, the antimicrobial component of the topical composition includes a quaternary ammonium compound that, when diluted to a 1% solution, will kill microorganisms such as E. coli, Staphylococcus species, and Pseudomonas species or at least hold these microorganisms at stasis, or prevent significant growth of the number of microorganisms. The quaternary ammonium compound of the antimicrobial component of the topical composition also preferably "kills" viruses, such as the herpes simplex viruses (type-1 and type-2) (HSV-1 and HSV-2) and rhinovirus. For example, the quaternary ammonium compound of the antimicrobial component may make up about 1% of the weight of the topical composition. Preferably, the quaternary ammonium compound makes up about 0.1 to about 0.2% of the total weight of the topical composition.
Examples of hydrophobic materials that can be used in the topical composition of the present invention include, without limitation, fragrances and botanical oils. Hydrophobic materials that moisturize, protect, act as emollients, or otherwise therapeutically benefit the skin are another example of hydrophobic materials that can be employed as the hydrophobic component of the topical composition according to the present invention. Water soluble moisturizers and emollients may also be employed.
When moisturizers or emollients are employed in the topical composition of the present invention, the moisturizers or emollients employed or the proportions in which the moisturizers or emollients are employed preferably do not significantly diminish the antimicrobial activity of the quaternary ammonium compound of the antimicrobial component of the topical composition. Exemplary moisturizers and emollients that can be included in the topical composition include, without limitation, glycerol, petrolatum, mineral oil, and silicone oils.
Hydrophobic (i.e.. "water hating") components of the topical composition can be emulsified, or suspended, in the water of the topical composition with surfactants. which are also commonly referred to in the art as emulsifiers. Since quaternary ammonium compounds are cationic, or positively charged ionic, compounds, anionic substances, such as anionic surfactants, may diminish the antimicrobial and other properties of the quaternary ammonium compound. The surfactants that are used in the topical composition to emulsify the hydrophobic components thereof are preferably cationic surfactants.
A cationic surfactant has a hydrophilic (i.e., "water loving") head and a lipophilic (i.e., "fat loving") tail. When mixed with water and a hydrophobic material, such as a silicone oil, to form an oil-in- water emulsion, the lipophilic tails of a number of surfactant molecules implant themselves into a quantity of the hydrophobic material to form a surfactant-coated droplet of the hydrophobic material, or micelle. The positively charged portion of a cationic surfactant is the hydrophilic portion thereof, which faces away from the hydrophobic material and toward the water, or aqueous, portion of the emulsion. As micelles are removed from an aqueous environment, such as the water of the topical composition, by evaporating the water or otherwise, the micelles release the droplet hydrophobic material.
Preferably, one or more quaternary ammonium compounds are employed as a cationic surfactant component of the topical composition of the present invention. The surfactant or surfactants of the cationic surfactant component are preferably used in the topical composition of the present invention in concentrations that are not irritating to tissues of the body, such as skin.
The topical composition may also include a preservative component of one or more preservatives. Preferably, the topical composition includes a blend of two or more preservatives. According to another aspect of the present invention, a method for manufacturing the topical composition includes mixing water soluble components of the topical composition in the water to form an aqueous solution, and separately mixing emulsifiers into the hydrophobic component of the topical composition. The mixture of the hydrophobic component and surfactant is heated. The aqueous solution is gradually added to the mixture of the hydrophobic component and surfactant while agitating the mixture to form a water-in-oil emulsion. As the concentration of the aqueous solution in the mixture increases, the emulsion inverts from a water-in-oil emulsion to an oil-in-water emulsion.
According to another aspect of the present invention, the topical composition is disposed on a sheet to form a wet wipe product. Woven or non- woven sheets of the types known to be useful for forming wet wipes are useful in the wet wipe product of the present invention. The sheet is impregnated or wetted with the topical composition of the present invention to form the wet wipe product.
In another aspect of the invention, the topical composition is applied in a thin layer to skin, the water evaporated from the topical composition, and the antimicrobial component or components released onto the skin. The topical composition can be applied to skin directly, such as in a spray, or by way of a wet wipe including the topical composition.
Alternatively, the topical composition can be rinsed from the skin soon after application thereof, in which case the topical composition is used similar to the manner in which soaps are used.
Other features and advantages of the present invention will become apparent to those of ordinary skill in the art through a consideration of the ensuing description and the appended claims.
BEST MODE(S) FOR CARRYING OUT THE INVENTION
According to one aspect, the present invention includes an antimicrobial topical composition with an antimicrobial component including a quaternary ammonium compound in a stable emulsion of water and oil. The oil is suspended in the water with at least one cationic surfactant. The antimicrobial topical composition of the present invention is substantially free of low molecular weight alcohols.
Preferably, the antimicrobial component of the topical composition includes a sufficient amount of the quaternary ammonium compound that, when diluted to a 1% solution, the quaternary ammonium compound will kill microorganisms such as E. coli, Staphylococcus species, and Pseudomonas species, as well as viruses such as herpes simplex viruses and rhinoviruses, or at least hold these microorganisms at stasis, thereby preventing a significant increase in the number of microorganisms exposed to the 1% solution and, thus, decreasing the likelihood of infection by microorganisms as a result of their presence on skin. For example, the quaternary ammonium compound employed as the antimicrobial component of the topical composition of the present invention can constitute up to about 1% of the weight of the topical composition. Preferably, the quaternary ammonium compound of the antimicrobial component makes up from about 0.1% to about 0.2% of the weight of the topical composition.
The antimicrobial component of the topical composition preferably includes the quaternary ammonium compound known in the art as benzethonium chloride, which has the chemical formula:
Figure imgf000010_0001
The antimicrobial activity of benzethonium chloride is noted in Federal Register, Vol. 56. No. 140, Monday, July 22, 1991, 33672-80, the disclosure of which is hereby incorporated by this reference in its entirety. Of course, topical compositions that include another quaternary ammonium compound as the antimicrobial component thereof are also within the scope of the present invention.
The hydrophobic component of the topical composition of the present invention can include hydrophobic, or oil-based, materials, such as oil-based fragrances, oil-based botanical extracts, and hydrophobic materials that moisturize, protect, or otherwise therapeutically benefit the skin.
Examples of hydrophobic materials that moisturize, protect, or otherwise therapeutically benefit the skin include, but are not limited to, silicone oils, mineral oils, petrolatum, and long chain, or high molecular weight, alcohols (i.e., alcohols having more than four carbon atoms), such as cetearyl alcohol.
In order to emulsify, or suspend, the hydrophobic (i.e., "water hating") components of the topical composition in the water, or aqueous, portion of the topical composition, the topical composition also includes one or more surfactants. Preferably, the surfactants used in the topical composition are present in amounts that will not irritate external tissues of the body, such as skin, with prolonged or frequent use.
The surfactants used in the topical composition are preferably cationic surfactants. This is because cationic surfactants are more compatible than other types of surfactants with the quaternary ammonium compound of the antimicrobial component of the topical composition and are, therefore, less likely than other types of surfactants to interfere with the antimicrobial activity or other properties of the quaternary ammonium compounds.
Exemplary cationic surfactants that may be used in the topical composition are quaternary ammonium compounds. One such class of quaternary ammonium compounds is benzalkonium chloride, which has the general formula:
Figure imgf000011_0001
Other quaternary ammonium compounds that may be used in the cationic surfactant component of the topical composition of the present invention include, without limitation, didecyldimethyl ammonium chloride (DDAC), dioctyldimethyl ammonium chloride (DOAC), and octyldecyldimethyl ammonium chloride (DODAC). Generally, quaternary ammonium compounds that are useful in the cationic surfactant component of the topical composition have the chemical formula:
Figure imgf000011_0002
where R, and R2 both include alkyl groups, R, and R2 both include benzyl groups, or one of R, and R2 includes a benzyl group and the other of R, and R2 includes an alkyl group. When quaternary ammonium compounds are used in the topical composition as cationic surfactants, the quaternary ammonium compounds preferably comprise up to about 1% to about 2% of the weight of the topical composition. More preferably, quaternary ammonium compounds that are employed in the topical composition as cationic surfactants collectively constitute about 0.1 % to about 0.5% or about 0.1% to about 1% of the weight of the topical composition. Behentrimonium methosulfate is an example of another surfactant that can be used in the topical composition of the present invention.
The topical composition may also include a preservative component with one or more preservatives. Preferably, the topical composition includes a blend of two or more preservatives. As is known to those of skill in the art, preservatives prevent the growth of microorganisms, such as bacteria, molds, and fungi. A blend of preservatives can facilitate a broader spectrum of activity if the preservatives of the blend prevent the growth of different microorganisms. Combinations of preservatives may also be capable of preventing the growth of microorganisms against which the individual preservatives may not be effective. In addition, in some cases, the total amount of one or more preservatives in the blend can be reduced without reducing the level of activity of those preservatives. Finally, due to the presence of multiple preservatives, the targeted microorganisms are less likely to develop resistance to any one of the preservatives in the blend. For these reasons, it can be said that, in the topical composition of the present invention, certain blends of preservatives are synergistic. In one embodiment of the topical composition of the present invention, the preferred combination of preservatives includes a one or more parabens. The parabens prevent or control the growth of bacterial microorganisms. Exemplary parabens that can be used in the topical composition include, but are not limited to, methylparabens, ethylparabens, propylparabens, and butylparabens. Preferably, the topical composition of the present invention includes methylparaben and propylparaben. Another exemplary preservative that may be employed in the topical composition of the present invention is a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4- isothiazolin-3-one. Potassium sorbate and other sorbic acid preservatives are examples of other preservatives that can be used in the topical composition. Topical compositions that include other preservatives and other mixtures of preservatives are also within the scope of the present invention.
The topical composition may also include other components, such as fragrances. botanical extracts, pH adjusting agents, or antimicrobial agents. Fragrances may be added to enhance the appeal of the product to consumers. The fragrances can be water soluble or oil-based. Botanical extracts, including both water soluble and hydrophobic materials, may be added to enhance the appeal of the product to consumers, impart a softer feel to the product, or help build healthier skin. The pH of the formulation can be controlled to avoid irritation to the user's skin, extend shelf-life, and generally enhance the product. Without pH adjusting agents, the pH of the topical composition may change over time, especially if there are long periods of time between manufacture and use of the product.
It is preferable to control or maintain the pH of the topical composition of the present invention. The pH of the topical composition is preferably from about 4 to about 8, and more preferably from about 5 to about 7. By maintaining the pH of the topical composition at such levels, irritation to the user's skin can be avoided, the shelf life of the topical composition can be maximized, and the quality of the topical composition can generally be optimized. Accordingly, the topical composition of the present invention preferably includes a pH adjusting agent. Preferably, the pH adjusting agent used in the topical composition does not irritate or have any other substantial adverse effects on skin. Exemplary pH adjusting agents that can be used in the topical composition include, but are not limited to, acids, such as sorbic acid, citric acid, or benzoic acid, bases, and known buffers. In addition, the salts of weak acids, amines, or any agent capable of adjusting pH without adversely affecting the skin can be used to regulate the pH of the topical composition of the invention.
According to another aspect of the present invention, some components of the topical composition can serve dual roles. For example, and not to limit the scope of the present invention, potassium sorbate could be used in the topical composition as both a pH adjusting agent and as a preservative. One embodiment of the topical composition of the present invention is a stable, creamy emulsion that includes moisturizers and emollients. Hydrophilic moisturizers or emollients, such as glycerol, or hydrophobic moisturizers or emollients, such as silicone oils, mineral oils, and petrolatum, can be used in the topical composition.
The following EXAMPLE illustrates, by way of example and not by way of limitation, a specific formulation of the stable, creamy emulsion embodiment of the topical composition of the present invention:
EXAMPLE 1
Figure imgf000014_0001
If the proportions of the hydrophobic materials and other components of the topical composition are too large, some of these components can diminish or inhibit the antimicrobial activity of the quaternary ammonium compound (e.g., benzethonium chloride) used in the antimicrobial component of the topical composition. Accordingly, the stable, creamy emulsion embodiment of the topical composition of the present invention preferably includes hydrophobic materials and other components in proportions that will not significantly diminish the antimicrobial properties of the antimicrobial quaternary ammonium compound (e.g., benzethonium chloride) of the topical composition. Preferably, hydrophobic materials make up less than about 20%) of the weight of the topical composition. More preferably, the topical composition has less than about 17% hydrophobic materials, by weight. Topical compositions that include less than about 15% hydrophobic materials, by weight, are even more preferred.
Stable, creamy emulsions with these proportions of hydrophobic materials can be manufactured in accordance with the hereinafter described method, in which the water soluble components of the topical composition, such as the quaternary ammonium compound of the antimicrobial component, are mixed in the water to form an aqueous solution, and the cationic surfactants, or emulsifiers, are separately mixed into the hydrophobic component of the topical composition.
The mixture of the hydrophobic component and surfactant is heated to facilitate the formation of an emulsion of the desired consistency. Preferably, the hydrophobic component and surfactant mixture is heated to a temperature of about 60° C. to about 100° C. Temperatures in the range of about 70° C. to about 90° C. are more preferred. As an example, the aqueous solution may be heated to a temperature of about 75 ° C. to about 80° C. while being mixed, while the hydrophobic component and surfactant mixture may be heated to a temperature of about 85 ° C. to about 90° C. while being mixed. Components of the topical composition that are sensitive to heat may be left out of the aqueous solution, the hydrophobic component, or the mixture until after the emulsion is cooled to a temperature that will not affect the activities of these heat-sensitive components. While the hydrophobic component and surfactant mixture is maintained at a substantially constant temperature, the aqueous solution is gradually added to the mixture with sufficient agitation to form small droplets of the aqueous solution in the hydrophobic component and, thus, to form a water-in-oil emulsion. The water-in-oil emulsion is preferably maintained at an increased temperature while the aqueous solution is mixed therein.
As the concentration of the aqueous solution in the emulsion increases, the emulsion inverts from a water-in-oil emulsion to an oil-in-water emulsion. Once the emulsion becomes an oil-in-water emulsion, the remainder of the aqueous solution can be added to the emulsion at an increased rate until the desired proportions of aqueous solution and hydrophobic components have been obtained. Mixing of the emulsion may be continued as the temperature thereof is decreased to a gel point of the emulsion and to cooler temperatures.
Of course, other techniques known in the art may also be used to make a stable, creamy emulsion incorporating teachings of the present invention.
An exemplary hand- wash formulation of an antimicrobial topical composition incorporating teachings of the present invention is illustrated in the following EXAMPLE:
EXAMPLE 2
Figure imgf000016_0001
Figure imgf000017_0001
In still another embodiment, the topical composition of the present invention is a more dilute, liquid emulsion that includes a small proportion of hydrophobic components. This liquid embodiment of the topical composition may have about 95% or more water, by weight. The following EXAMPLE illustrates, by way of example and not by way of limitation, a specific formulation of a liquid, or less viscous, embodiment of the topical composition of the present invention:
EXAMPLE 3
Figure imgf000017_0002
Figure imgf000018_0001
The less viscous embodiments of the topical composition can be manufactured by known processes or by employing the method described above in reference to the manufacture of the stable, creamy emulsion embodiment of the topical composition, then further diluting the composition to the desired consistency.
Of course, some of the less viscous embodiments of the topical composition of the present invention need not include any hydrophobic components.
As an example of the use of topical compositions incorporating teachings of the present invention, including the stable, creamy emulsion embodiments, as well as the less viscous embodiments, the topical composition may be rubbed onto to skin (e.g., on hands). When kept in contact with the skin for at least about ten or fifteen seconds, the topical composition of the present invention eliminates many microorganisms, including bacteria and some viruses.
The topical composition can be left on the skin, wherein water evaporates from the skin and the remaining components of the topical composition, such as antimicrobial component, the hydrophobic components, and the surfactants remain on the skin or are absorbed into the skin. When left on the skin, the topical composition demonstrates prolonged activity against some microorganisms. For example, when left on the skin, the topical composition remains active against Staphylococcus aureus for as long as four hours or more. In one study wherein the topical composition was left on skin, at four hours after application of the topical composition to the skin the number of S. aureus on the skin was about 98.8% less than the number of S. aureus on the skin prior to application of the topical composition. As another example, the topical composition remains effective against E. coli for at least about two hours. After fifteen seconds, the topical composition reduces the number of E. coli by about 99.999%. At ten minutes following application of the topical composition, the number of E. coli increased, but remained at about 55.3% less than the number of E. coli prior to application of the topical composition. After two hours, the number of E. coli on the skin was still about 36.9% less than the number of E. coli prior to application of the topical composition.
Alternatively, after applying the topical composition to the skin, the topical composition can be removed from the skin, such as by rinsing with water (i.e., used similarly to a soap). When rinsed from skin, a topical composition with less than about 20%, by weight, hydrophobic components does not leave a tacky or oily residue on the skin, as may occur with many conventional creamy emulsions that have higher proportions of hydrophobic components.
Topical compositions incorporating teachings of the present invention are also effective in reducing populations of Mycobacterium Bovis, which causes tuberculosis. When Mycobacterium Bovis is exposed to an exemplary topical composition incorporating teachings of the present invention, the population of Mycobacterium Bovis is reduced by about 96.3%. When the exposure time is increased to about 30 seconds, the number of Mycobacterium Bovis bacteria is reduced by about 91.4%. Topical compositions incorporating teachings of the present invention may also have antiviral activities. These antiviral activities may be exhibited with long exposure times, as well as with relatively short exposure times, such as when the topical composition is applied to the skin and, shortly thereafter, removed from the skin. Topical compositions according to the present invention may also kill viruses when left on the skin for longer periods of time. The following TABLE includes examples of viruses against which the topical composition of EXAMPLE 2, as well as other embodiments of topical compositions incorporating teachings of the present invention, is effective. As shown in the following TABLE, the topical compositions of the present invention may reduce the number of viruses significantly, such as by greater than about 99%, in exposure times as short as about 15 seconds or less. TABLE
Figure imgf000020_0001
According to another aspect of the present invention, the liquid embodiment of the topical composition is disposed on a sheet to form a wet wipe product. Woven or non- woven sheets of the types known to be useful for forming wet wipes are useful in the wet wipe product of the present invention. The sheet is impregnated or wetted with the topical composition of the present invention to form the wet wipe product.
In another aspect of the invention, the liquid embodiment of the topical composition is applied in a thin layer to skin, the water evaporated from the topical composition, and the antimicrobial component released onto the skin. The topical composition can be applied to skin directly, by spraying, or by way of a wet wipe including the liquid topical composition. When left on the skin for about ten or fifteen seconds or more, the liquid embodiment of the topical composition reduces the number of bacteria and virus particles on the skin in a manner similar to that of the creamy emulsion embodiment of the topical composition.
While certain representative embodiments and details have been shown for purposes of illustrating the invention, it will be apparent to those skilled in the art that various changes in the invention disclosed herein may be made without departing from the scope of the invention, which is defined in the appended claims.

Claims

What is claimed is:
An antimicrobial topical composition, comprising: water; an antimicrobial component comprising benzethonium chloride; a hydrophobic component; and a cationic surfactant component for emulsifying said hydrophobic component in said water.
2. The antimicrobial topical composition of claim 1, wherein said cationic surfactant component comprises the general formula:
Figure imgf000021_0001
where R, and R2 both comprise alkyl groups, R, and R2 both comprise benzyl groups, or one of R, and R2 comprises a benzyl group and the other of R, and R2 comprises an alkyl group.
3. The antimicrobial topical composition of claim 1, wherein said antimicrobial component comprises less than about 1% of the weight of said antimicrobial topical composition.
4. The antimicrobial topical composition of claim 1, wherein said antimicrobial component comprises about 0.1 % to about 0.2% of the weight of said antimicrobial topical composition.
5. The antimicrobial topical composition of claim 1, wherein said cationic surfactant component comprises less than about 1% of the weight of said antimicrobial topical composition.
6. The antimicrobial topical composition of claim 1, comprising about
0.1% to about 0.5% of said cationic surfactant component, by weight.
7. The antimicrobial topical composition of claim 1, further comprising more than one preservative.
8. The antimicrobial topical composition of claim 7, wherein said more than one preservative comprises a synergistic blend of methylparaben and propylparaben.
9. The antimicrobial topical composition of claim 7, wherein: said hydrophobic component comprises petrolatum, a mineral oil, a silicone oil, or an oil-based fragrance, said hydrophobic component forming a stable, creamy emulsion with said water and comprising less than about 20%, by weight, of the composition; said cationic surfactant comprises at least one of benzalkonium chloride, didecyldimethyl ammonium chloride, dioctyldimethyl ammonium chloride, and decyloctyldimethyl ammonium chloride; and at least one of said more than one preservative comprises sorbic acid or a salt thereof, diazolidinyl urea, methylparaben, ethylparaben, propylparaben, butylparaben, or a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4- isothiazolin-3-one.
10. The antimicrobial topical composition of claim 9, comprising less than about 15%, by weight, of said hydrophobic component, said hydrophobic component forming a stable, creamy emulsion with said water.
11. The antimicrobial topical composition of claim 1 , comprising at least about 95%, by weight, of said water.
12. The antimicrobial topical composition of claim 1, said topical composition being substantially free of low molecular weight alcohols.
13. A wet wipe comprising a sheet wetted with the antimicrobial topical composition of any of claims 4, 10, 1 1, and 12.
14. A method for reducing a number of microorganisms on a surface, comprising applying to the surface a substantially low molecular weight alcohol-free topical composition with a benzethonium chloride antimicrobial agent, a hydrophobic component, and a cationic surfactant.
15. The method of claim 14, further comprising removing said topical composition from the surface.
16. The method of claim 14, further comprising leaving said topical composition on the surface.
17. A method for manufacturing an antimicrobial topical composition, comprising: forming a mixture of a cationic surfactant and a hydrophobic component; heating said mixture; forming an aqueous solution of water and an antimicrobial component comprising a quaternary ammonium compound; adding said aqueous solution gradually to said mixture; agitating said mixture during said adding to form a water-in-oil emulsion; inverting said water-in-oil emulsion to form an oil-in-water emulsion; and diluting said oil-in-water emulsion.
18. The method of claim 16, wherein said forming said aqueous solution comprises dissolving benzethonium chloride in said water.
19. The method of claim 16, wherein said forming said mixture comprises mixing at least one cationic surfactant with said hydrophobic component.
20. The method of claim 16, wherein said heating comprises heating said mixture to a temperature of about 60° C. to about 100° C.
21. The method of claim 16, wherein said heating comprises heating said mixture to a temperature of about 70° C. to about 80° C.
22. The method of claim 16, further comprising substantially maintaining a temperature of said water-in-oil emulsion during said adding.
23. The method of claim 16, wherein said diluting comprises adding water to said oil-in-water emulsion to form a stable, creamy emulsion comprising less than about 20%, by weight, of said hydrophobic component.
24. The method of claim 16, wherein said diluting comprises adding water to said oil-in-water emulsion to form a liquid emulsion comprising at least about 95% of said water.
PCT/US2000/025853 1999-09-22 2000-09-21 Antimicrobial topical composition and methods Ceased WO2001021138A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU75980/00A AU7598000A (en) 1999-09-22 2000-09-21 Antimicrobial topical composition and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40137699A 1999-09-22 1999-09-22
US09/401,376 1999-09-22

Publications (1)

Publication Number Publication Date
WO2001021138A1 true WO2001021138A1 (en) 2001-03-29

Family

ID=23587502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/025853 Ceased WO2001021138A1 (en) 1999-09-22 2000-09-21 Antimicrobial topical composition and methods

Country Status (2)

Country Link
AU (1) AU7598000A (en)
WO (1) WO2001021138A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1153544A3 (en) * 2000-05-11 2001-11-21 Unilever Plc Antimicrobial cleansing composition and wipe
WO2003053144A1 (en) * 2001-12-20 2003-07-03 Kimberly-Clark Worldwide, Inc. Antimicrobial pre-moistened wipers
JP2004529148A (en) * 2001-04-24 2004-09-24 ザ プロクター アンド ギャンブル カンパニー Wet type antibacterial wipes
WO2007054746A3 (en) * 2005-11-10 2008-05-29 Biotech Internat Ltd An aqueous biocidal composition, and methods and devices for dispersing it
WO2009101409A1 (en) * 2008-02-13 2009-08-20 Fraser, James Sanitiser composition
WO2009103990A3 (en) * 2008-02-20 2010-10-14 Enviroquest Group Limited Exterior surface treatment system
DE102010013275A1 (en) * 2010-03-29 2011-09-29 Beiersdorf Ag Microbiologically stable, application-friendly W / O preparations
US8481480B1 (en) 2012-04-30 2013-07-09 Uyen T. Lam Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol
US9357771B2 (en) 2012-12-17 2016-06-07 Kimberly-Clark Worldwide, Inc. Foaming sanitizing formulations and products including a quaternary ammonium compound
US9717669B2 (en) 2012-07-23 2017-08-01 Innovative Biodefense, Inc. Topical sanitizing formulations and uses thereof
US20170266090A1 (en) * 2016-03-17 2017-09-21 Marvel Technologies Usa, Llc Antimicrobial compositions that are dermatologically non-drying
US11116220B2 (en) 2017-12-22 2021-09-14 Ecolab Usa Inc. Antimicrobial compositions with enhanced efficacy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705532A (en) * 1995-11-13 1998-01-06 The Trustees Of Columbia University Of The City Of New York Triple antimicrobial composition
US5759557A (en) * 1995-02-22 1998-06-02 Bausch & Lomb Incorporated Skin care composition
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759557A (en) * 1995-02-22 1998-06-02 Bausch & Lomb Incorporated Skin care composition
US5705532A (en) * 1995-11-13 1998-01-06 The Trustees Of Columbia University Of The City Of New York Triple antimicrobial composition
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1153544A3 (en) * 2000-05-11 2001-11-21 Unilever Plc Antimicrobial cleansing composition and wipe
JP2004529148A (en) * 2001-04-24 2004-09-24 ザ プロクター アンド ギャンブル カンパニー Wet type antibacterial wipes
WO2003053144A1 (en) * 2001-12-20 2003-07-03 Kimberly-Clark Worldwide, Inc. Antimicrobial pre-moistened wipers
AU2002357689B2 (en) * 2001-12-20 2008-10-23 Kimberly-Clark Worldwide, Inc. Antimicrobial pre-moistened wipers
US7838447B2 (en) 2001-12-20 2010-11-23 Kimberly-Clark Worldwide, Inc. Antimicrobial pre-moistened wipers
WO2007054746A3 (en) * 2005-11-10 2008-05-29 Biotech Internat Ltd An aqueous biocidal composition, and methods and devices for dispersing it
WO2009101409A1 (en) * 2008-02-13 2009-08-20 Fraser, James Sanitiser composition
WO2009103990A3 (en) * 2008-02-20 2010-10-14 Enviroquest Group Limited Exterior surface treatment system
DE102010013275A1 (en) * 2010-03-29 2011-09-29 Beiersdorf Ag Microbiologically stable, application-friendly W / O preparations
US8481480B1 (en) 2012-04-30 2013-07-09 Uyen T. Lam Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol
GB2515696B (en) * 2012-04-30 2020-11-25 Kimberly Clark Co Use of an anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol
US9717669B2 (en) 2012-07-23 2017-08-01 Innovative Biodefense, Inc. Topical sanitizing formulations and uses thereof
US9357771B2 (en) 2012-12-17 2016-06-07 Kimberly-Clark Worldwide, Inc. Foaming sanitizing formulations and products including a quaternary ammonium compound
GB2523959B (en) * 2012-12-17 2017-09-13 Kimberly Clark Co Foaming sanitizing formulations and products including a quaternary ammonium compound
US20170266090A1 (en) * 2016-03-17 2017-09-21 Marvel Technologies Usa, Llc Antimicrobial compositions that are dermatologically non-drying
US11116220B2 (en) 2017-12-22 2021-09-14 Ecolab Usa Inc. Antimicrobial compositions with enhanced efficacy
US11930819B2 (en) 2017-12-22 2024-03-19 Ecolab Usa Inc. Antimicrobial compositions with enhanced efficacy

Also Published As

Publication number Publication date
AU7598000A (en) 2001-04-24

Similar Documents

Publication Publication Date Title
US6410039B1 (en) Protective topical composition, products including the same, and methods
US5512199A (en) Hand wipe solution
KR100461931B1 (en) Antimicrobial Compositions and Wet Wipes Including The Same
US4975217A (en) Virucidal composition, the method of use and the product therefor
US5591442A (en) Skin antiseptic and hand disinfectant
US6723689B1 (en) Emollient alcohol skin disinfecting formulation
KR100929469B1 (en) Antimicrobial agents
TWI378796B (en) Composition and method for pre-surgical skin disinfection
EP0963157B1 (en) Hydroalcoholic compositions thickened using surfactant/polymer complexes
US5767163A (en) Lubricating and/or germicidal composition
US4321277A (en) Germicidal use of compositions containing certain quaternary ammonium compounds
US6413921B1 (en) Antimicrobial composition containing parachlorometaxylenol (PCMX)
JP2010505964A (en) How to inactivate viruses
WO2002055055A2 (en) Fast-acting antimicrobial lotion with enhanced efficacy
US5492932A (en) Lubrication germicidal composition
WO2001021138A1 (en) Antimicrobial topical composition and methods
US20060204558A1 (en) Antimicrobial pet wipes and methods
US20120055510A1 (en) Antiseptic Wipes
US20020106399A1 (en) Antimicrobial wipe
US20120295940A1 (en) Compositions for treating mastitis
GB2587894A (en) Topical sanitisation composition
RU2113861C1 (en) Antiseptic preparation "lysanin op"
RU2714885C1 (en) Disinfectant composition for hands
JPH0316542A (en) Cleansing-wiping material
US20170266090A1 (en) Antimicrobial compositions that are dermatologically non-drying

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC DATED 29-08-2002

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP